Nitroglycerine (GTN) Infusion
Infusion pump continuous infusion preparation (200 mcg/mL), rapid hemodynamic titration, and hypotension surveillance protocol.
Infusion Pump Infusion Preparation (Standard Concentration)
| Ampoule Presentation | 5 mL ampoule (5 mg/mL of nitroglycerine) |
|---|---|
| Nitroglycerine Dose | 50 mg (10 mL = two 5 mL ampoules) |
| Compatible Diluent | D5W or 0.9% Sodium Chloride (NS) |
| Final Volume | 250 mL |
| Final Concentration | 200 mcg/mL (0.2 mg/mL) |
| Stability | 24 hours at room temperature |
Materials Required
- Nitroglycerine ampoules 5 mg/mL (5 mL) × 2
- 250 mL 0.9% Sodium Chloride (NS) or 5% Dextrose (D5W)
- 10 mL sterile syringe
- Sterile drawing-up needle / filter needle
- Dedicated infusion pump label
- Non-PVC (polyethylene-lined) extension line (100 cm)
- Alcohol chlorhexidine swabs
Preparation Procedure (Aseptic Non-Touch Technique)
- Verification: Verify the written physician order, patient identity, clinical indication, and baseline blood pressure.
- PDE-5 Inhibitor Screen: Confirm the patient has not taken sildenafil or vardenafil in the past 24 hours, or tadalafil in the past 48 hours.
- Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
- Ampoule Check: Check each nitroglycerine ampoule for:
- Correct drug and strength, glyceryl trinitrate (5 mg/mL)
- Expiry date
- Container integrity, clarity, and absence of precipitate or discoloration
- Discard: Remove 10 mL from 250 mL of 0.9% Sodium Chloride or D5W(Volume in the bag 240 mL).
- Withdrawal: Open two ampoules of nitroglycerine. Withdraw 5 mL from each ampoule into a 10 mL syringe (Total nitroglycerine drawn: 10 mL = 50 mg nitroglycerine).
- Dilution: Add 10 mL of nitroglycerine to 240 mL of 0.9% Sodium Chloride or D5W to a final volume of 250 mL.
- Mixing: Gently invert the preparation several times to ensure uniform mixing.
- Visual Inspection: Inspect solution to ensure it is clear, colorless, and free of visible particles.
- Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
- Infusion Pump Setup: Prime a non-PVC extension set and install into the infusion pump.
🔒 Tubing Policy: Standard PVC tubing absorbs a large and variable fraction of nitroglycerine, so the patient receives less than the programmed dose. Always use non-PVC (polyethylene) administration sets, and re-titrate carefully if the tubing type is changed.
⚠️ Line Access: Nitroglycerine may be infused via a peripheral or central line. Use a dedicated lumen so bolus flushes of other drugs do not deliver an unintended nitroglycerine bolus.
Dose-Dependent Hemodynamic Effects
Nitroglycerine releases nitric oxide in vascular smooth muscle. Venous capacitance vessels respond at low doses; arterioles need higher doses. Thresholds vary between patients, so titrate to clinical response.
Low Dose (Venodilation)
- Venous pooling lowers preload, LVEDP, and pulmonary congestion
- Reduces myocardial oxygen demand
Coronary Effect
- Dilates epicardial coronary arteries and collaterals
- Relieves ischemic chest pain and coronary vasospasm
High Dose (Arteriolar Dilation)
- Lowers systemic vascular resistance and afterload
- Greater risk of hypotension and reflex tachycardia
Administration & Titration
Recommended Dosing Parameters
- Administration Route: Administer via infusion pump through a non-PVC line; dedicated lumen preferred.
- Recommended Starting Dose: 5 to 10 mcg/min.
- Titration Step: Increase by 5 to 10 mcg/min every 3 to 5 minutes, according to target response and blood pressure.
- Usual Maximum: 200 mcg/min. Higher doses only under direct intensivist supervision.
- Tolerance: Tachyphylaxis may develop after 24 to 48 hours of continuous infusion; reassess the need and dose.
- Weaning: Taper gradually to avoid rebound hypertension or ischemia.
- Infusion Continuity: Do not allow the infusion to run out. An infusion can be made up to a maximum of 1 hour in advance and labelled clearly with contents and expiry.
- Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes discoloured, cloudy, or contaminated.
Hemodynamic Monitoring Requirements
- Record blood pressure every 3 to 5 minutes during initiation and each titration step; continuous arterial monitoring preferred at higher doses.
- Monitor heart rate and continuous ECG for reflex tachycardia and ischemic changes.
- Reassess chest pain score, respiratory rate, oxygen saturation, and signs of pulmonary congestion.
- With prolonged high-dose infusion, consider methemoglobin levels if cyanosis or unexplained hypoxemia develops.
Contraindications & Cautions
- PDE-5 Inhibitors: Recent sildenafil, vardenafil, or tadalafil use; risk of severe, refractory hypotension.
- Right Ventricular Infarction: Preload-dependent; nitrates can cause profound hypotension.
- Hypovolemia: Uncorrected volume depletion.
- Fixed Outflow Obstruction: Severe aortic stenosis or hypertrophic obstructive cardiomyopathy.
- Raised Intracranial Pressure: Cerebral vasodilation may worsen ICP.
Hypotension Surveillance & Response Protocol
Nitroglycerine, principal acute hazard is sudden hypotension. Its short half-life means effects wear off within minutes of stopping the infusion.
Expected Response
- Blood pressure within prescribed target
- Improving chest pain or breathlessness
- Heart rate stable
- Patient alert and well perfused
Hypotension (SBP < 100 mmHg or Symptomatic):
- STOP or reduce infusion immediately.
- Position the patient supine with legs raised, unless pulmonary edema makes this unsafe.
- Notify clinician promptly.
- Recheck blood pressure every 2 to 3 minutes until stable.
- Document event in patient clinical record.
Nitroglycerine Infusion Rate Chart (200 mcg/mL)
Shows the infusion pump rate (mL/hr) for each dose, and the total volume infused over 24 hours (50 mg in 250 mL).
| Dose (mcg/min) |
Pump Rate (mL/hr) |
Total Volume per 24 hr (mL) |
|---|---|---|
| 5 | 1.5 | 36 |
| 10 | 3 | 72 |
| 15 | 4.5 | 108 |
| 20 | 6 | 144 |
| 30 | 9 | 216 |
| 40 | 12 | 288 |
| 50 | 15 | 360 |
| 60 | 18 | 432 |
| 80 | 24 | 576 |
| 100 | 30 | 720 |
| 120 | 36 | 864 |
| 150 | 45 | 1080 |
| 175 | 52.5 | 1260 |
| 200 | 60 | 1440 |
Infusion Conversion (Solution Concentration 200 mcg/mL)
Standard equations for a 200 mcg/mL solution (50 mg in 250 mL):
Rate (mL/hr) = [ Dose (mcg/min) × 60 ] / 200
Shortcut: Rate = Dose × 0.3
Dose (mcg/min) = [ Rate (mL/hour) × Concentration (200 mcg/mL) ] / 60
Shortcut: 1 mL/hr ≈ 3.33 mcg/min
'Shortcut' example: 20 mcg/min → 20 × 0.3 = 6 mL/hr.